Palantir Technologies Inc. - Class A Common Stock (PLTR)
198.78
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 9th, 9:15 AM EDT
Detailed Quote
Previous Close
198.78
Open
-
Bid
200.50
Ask
200.70
Day's Range
N/A - N/A
52 Week Range
106.37 - 207.52
Volume
653,672
Market Cap
403.02M
PE Ratio (TTM)
320.61
EPS (TTM)
0.6
Dividend & Yield
N/A (N/A)
1 Month Average Volume
22,847,053
Chart
About Palantir Technologies Inc. - Class A Common Stock (PLTR)
Palantir Technologies is a public software company that specializes in big data analytics and provides platforms for organizations to integrate, visualize, and analyze large amounts of data from disparate sources. Its flagship products, Palantir Gotham and Palantir Foundry, are designed to assist government agencies and commercial enterprises in making data-driven decisions by offering advanced analytical capabilities, collaborative tools, and visualization features. The company has gained prominence for its work with intelligence and defense organizations, as well as its growing presence in various industries such as finance, healthcare, and manufacturing, enabling clients to derive actionable insights and enhance their operational efficiency. Read More
Watts Water Technologies has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 1...
Zeta Global (NYSE:ZETA) unveiled AthenaOS, an AI-focused operating system intended to bring together customer data, intelligence, workflows and business applications across marketing and other enterprise functions.
At the company’s Zeta Live event, Chief Technology Officer and Head of Product Chris
What Happened? A number of stocks jumped in the afternoon session after a Gulf tanker attack slowed traffic through the strait, while hurricane-driven produc...
What Happened? Shares of EV charging infrastructure provider Blink Charging (NASDAQ:BLNK) fell 6.2% in the afternoon session after Brighton & Hove City Counc...
What Happened? A number of stocks jumped in the afternoon session after a comprehensive industry report revealed that infrastructure service spending surged ...
BigBear.ai carries 31% short interest and oversold technicals, while growing government contracts, expanding margins, and $410 million in cash fuel potential short-squeeze and profitability catalysts.
Over the last six months, Hamilton Lane’s shares have sunk to $85.26, producing a disappointing 12.2% loss - a stark contrast to the S&P 500’s 15.2% gain. Th...
What Happened? Shares of racing, gaming, and entertainment company Churchill Downs (NASDAQ:CHDN) fell 5.2% in the afternoon session after Mizuho analyst Ben ...
What Happened? Shares of data center products and services company Vertiv (NYSE:VRT) fell 3.5% in the afternoon session after downward momentum continued as ...
AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).
Governments and critical infrastructure operators are rapidly adopting AI for threat detection, intelligence, autonomous systems and cybersecurity as global spending accelerates